Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WARPNINE Foundation is an Australian non-profit organization dedicated to improving the survival rates of patients with gastrointestinal (GI) cancers, with a specific focus on pancreatic, stomach, and esophageal cancers. Founded by leading oncologists, the foundation raises funds to support innovative medical research and clinical trials that might otherwise lack funding. By bridging the gap between laboratory research and clinical application, WARPNINE aims to accelerate the development of new treatments and diagnostic tools. The organization works closely with the Royal North Shore Hospital and the University of Sydney to foster a collaborative research environment. Their efforts are primarily directed toward forgotten cancers that receive significantly less funding than more common malignancies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WARPNINE Foundation.